Hemoglobin News and Research

RSS

Low hemoglobin levels are a predictor of increased risk of death among heart failure patients

Hemoglobin (Hgb) is the major substance in red blood cells, and its level indicates the blood's ability to carry oxygen throughout the body. Studies have shown that low hemoglobin, which may result in anemia, is more common among patients with heart failure than it is among people in the general population.

17 Aug 2005

Oral medications may control symptoms of Type II diabetes in children just as well as insulin injections

According to the medical records of 26 children diagnosed with the disease, oral medications reduced levels of a compound in the blood called hemoglobin A1C by an average of 2 percentage points.

15 Aug 2005

New insight into how protein E75 may control circadian rhythms and metabolic processes

University of Toronto researchers have gained new insight into how a specific protein may control circadian rhythms and metabolic processes, which has implications for treating cholesterol-related diseases.

28 Jul 2005

Quality of care may vary in association with the characteristics of individual physicians and their practices

Certain physician characteristics and practice-setting characteristics are associated with Medicare beneficiaries receiving routine preventive services below the national goals, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.

27 Jul 2005

Chromium picolinate significantly reduces weight gain associated with common antidiabetic medication

...according to a study released today. Researchers at the Pennington Biomedical Research Center (PBRC), who conducted the study, also found that chromium significantly improved blood sugar control and insulin sensitivity.

16 Jun 2005

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.

16 Jun 2005

Oral liquid Hydroxyurea promising for long-term use in babies with sickle cell disease

15 Jun 2005

Tight glucose control lowers CVD by about 50 percent in diabetes

A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes.

12 Jun 2005

Vitamin B6 decreases risk of colorectal cancer

According to a study published in the American Gastroenterological Association (AGA) journal Gastroenterology, women with a high dietary intake of vitamin B6 over several years have a decreased risk of colorectal cancer (CRC).

5 Jun 2005

Sickle cell protects against malari

In this month's issue of the open access journal PLoS Medicine, Dr. Thomas N. Williams and colleagues from Kilifi, Kenya, show that the protection against malaria given by carrying the gene for sickle cell haemoglobin may involve the immune system.

30 May 2005

Viramidine demonstrates anti-HCV Genotype 1 activity that compares favorably to Ribavirin

Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).

23 Apr 2005

Researchers have identified a new clinical syndrome

Researchers have identified a new clinical syndrome that produces serious and sometimes fatal symptoms in a variety of seemingly unrelated diseases. The syndrome, described in the April 6 issue of the Journal of the American Medical Association, is caused by hemolysis, the destruction of red blood cells.

5 Apr 2005

Method of gene therapy accurately corrects mutations in disease-causing genes

Harnessing the strength of a natural process that repairs damage to the human genome, a researcher from UT Southwestern Medical Center has helped establish a method of gene therapy that can accurately and permanently correct mutations in disease-causing genes.

5 Apr 2005

Hemoglobin News and Research

Low hemoglobin levels are a predictor of increased risk of death among heart failure patients

Oral medications may control symptoms of Type II diabetes in children just as well as insulin injections

New insight into how protein E75 may control circadian rhythms and metabolic processes

Quality of care may vary in association with the characteristics of individual physicians and their practices

Chromium picolinate significantly reduces weight gain associated with common antidiabetic medication

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Oral liquid Hydroxyurea promising for long-term use in babies with sickle cell disease

Tight glucose control lowers CVD by about 50 percent in diabetes

Vitamin B6 decreases risk of colorectal cancer

Sickle cell protects against malari

Viramidine demonstrates anti-HCV Genotype 1 activity that compares favorably to Ribavirin

Researchers have identified a new clinical syndrome

Method of gene therapy accurately corrects mutations in disease-causing genes

Method of gene therapy that can accurately and permanently correct mutations in disease-causing genes

Wolbachia genome reveals new targets to combat infectious disease

Molecule that causes secondary stroke

Images of brain activity may hold clues to the onset of schizophrenia

$3.2 million for two shock-related studies

Mountain dwellers live longer

Process behind cellular export of iron may help to explain human hemochromatosis

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News